Skip to content

Analysis of Differential Proteins and Maternal Influencing Factors of Septic Shock in Neonates

Analysis of Differential Proteins and Maternal Influencing Factors of Septic Shock in Neonates Born to ≤32-week Preterm Infants or Infected Mothers During Pregnancy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06206590
Enrollment
116
Registered
2024-01-16
Start date
2023-11-01
Completion date
2025-12-31
Last updated
2024-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal Disease

Brief summary

1\. Explore 32 weeks of premature infants or maternal pregnancy infection of newborn septic shock maternal influence factors. 2. Through maternal blood samples before delivery and labor cord blood sample screening and septic shock related proteomics analysis, explore the relationship between the difference protein and septic shock and prognosis, and explore the pathway mechanism, in order to prevent and reduce the occurrence of septic shock in premature infants

Detailed description

The birth cohort was established with 32 weeks of premature infants or maternal infection during pregnancy.Whole proteomic analysis was performed on maternal blood before delivery and umbilical cord blood samples at delivery,and screscreen differential proteins associated with septic shock and classify these proteins as leak factor into exposed and non-exposed groups for cohort study.The incidence and mortality of shock,severe brain injury and BPD in the two groups were compared, and the mechanism of the differential protein was studied to provide early warning in children with septic shock.

Interventions

OTHERWhole-proteomic assay

Whole-proteomic analysis was performed on all the blood samples

Sponsors

Guangdong Women and Children Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Days to 1 Days
Healthy volunteers
No

Inclusion criteria

* All ≤32-week premature infants admitted to our NICU; All newborns delivered by the mother infected during pregnancy

Exclusion criteria

* Not delivered in our hospital; congenital cardiovascular development malformation, fetal malformation, genetic metabolic diseases, etc

Design outcomes

Primary

MeasureTime frame
The incidence and mortality of shock1/10/2025

Countries

China

Contacts

Primary Contactdongju ma
864970051@qq.com+86 188 9853 7230

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026